(19)
(11) EP 4 824 094 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24829102.3

(22) Date of filing: 13.12.2024
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
A61K 40/31(2025.01)
A61P 35/00(2006.01)
A61K 40/15(2025.01)
A61K 40/42(2025.01)
(52) Cooperative Patent Classification (CPC):
A61K 2239/13; A61K 2239/17; A61K 2239/21; A61K 2239/22; A61K 2239/48; A61P 35/00; A61K 40/15; A61K 40/4219; A61K 40/31; C07K 16/2866; C07K 2317/622
(86) International application number:
PCT/EP2024/086312
(87) International publication number:
WO 2025/125610 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 15.12.2023 EP 23217219

(71) Applicant: Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft
13125 Berlin (DE)

(72) Inventors:
  • HÖPKEN, Uta Elisabeth
    14057 Berlin (DE)
  • REHM, Armin
    14057 Berlin (DE)
  • MASSARO, Marialucia
    10409 Berlin (DE)
  • BUNSE, Mario
    10961 Berlin (DE)

(74) Representative: Hertin und Partner Rechts- und Patentanwälte PartG mbB 
Kurfürstendamm 63
10707 Berlin
10707 Berlin (DE)

   


(54) CHIMERIC ANTIGEN RECEPTOR DIRECTED AGAINST THE CHEMOKINE RECEPTOR CCR7